Bruker , Adeptrix buy in9 Jan 2021 09:48
Best sentence on press release.
Hopefully they have their eye on Affimers.
Our partnership is expected to accelerate collaborations with developers of antibodies and other affinity reagents to expand the range of available protein biomarker Affi-BAMS assays for liquid biopsies, cell and tissue-based applications.
Dr. Rohan A. Thakur, EVP of Life Sciences Mass Spectrometry at Bruker Daltonics, commented: “Our partnership with Adeptrix is important as it enables wider access to critical BAMS assay technology for translational research using MALDI-TOF mass spectrometry, which is capable of analyzing thousands of samples per day. Our partnership is expected to accelerate collaborations with developers of antibodies and other affinity reagents to expand the range of available protein biomarker Affi-BAMS assays for liquid biopsies, cell and tissue-based applications.”
https://www.businesswire.com/news/home/20210106005853/en/Adeptrix-Closes-Series-A-Financing-to-Commercialize-BAMS™-Bioanalytical-Reagents-for-Life-Science-Research